KW 27.72 Kennedy-Wilson Holdings Inc $KW Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 12:53 PM

KW 27.72 Kennedy-Wilson Holdings Inc $KW Hit a 52 week high of 27.97 Currently at 27.72 -0.18 -0.65% With a day low of 27.62 and a total volume of 7,498.

KW Kennedy-Wilson Holdings Inc Recent Headline News

Kennedy-Wilson Holdings' (KW) CEO Bill McMorrow on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 3:53AM CST

KW: 27.85 (-0.05)

Kennedy-Wilson Holdings (KW) Downgraded From Buy to Hold
at The Street - Fri Nov 07, 8:27AM CST
Kennedy-Wilson Holdings (KW) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C.
KW: 27.85 (-0.05)

Kennedy-Wilson beats 3Q profit forecasts
Automated Insights - Thu Nov 06, 4:04AM CST
BEVERLY HILLS, Calif. (AP) _ Kennedy-Wilson Holdings Inc. (KW) on Thursday reported a loss of $3 million in its third quarter.
KW: 27.85 (-0.05)

Kennedy-Wilson Holdings beats by $0.53, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:10PM CST

KW: 27.85 (-0.05)

Kennedy Wilson Reports Third Quarter 2014 Earnings
Business Wire - Wed Nov 05, 3:27PM CST
Kennedy-Wilson Holdings, Inc. (NYSE: KW) today reported results for the third quarter of 2014.
KW: 27.85 (-0.05)

Leju Holdings Limited (LEJU) Jumps: Stock Rises 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 7:57AM CST
Leju Holdings Limited (LEJU) was a big mover last session, as the company saw its shares rise over 8% on the day.
JLL: 140.89 (+0.87), LEJU: 14.55 (+0.07), KW: 27.85 (-0.05)

Notable earnings after Wednesday’s close
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 4:35PM CST

CXO: 116.50 (+0.92), CODI: 16.90 (-1.40), EXXI: 7.06 (+0.04), JCOM: 56.14 (+0.39), ATSG: 8.52 (-0.13), GPOR: 53.48 (+0.01), ENS: 60.04 (-0.23), ECYT: 6.46 (+0.28), ALNY: 100.73 (+1.55), KGC: 2.41 (+0.07), GSM: 18.46 (-0.25), BKD: 32.85 (-0.23), DK: 30.94 (-0.24), AR: 54.83 (+0.05), IL: 9.45 (+0.36), DVR: 0.14 (-0.08), IO: 2.92 (+0.19), DEPO: 14.54 (-0.01), ETE: 61.82 (-0.16), AVG: 19.36 (-0.23), CSOD: 28.59 (-0.18), GNW: 8.31 (+0.19), ECOL: 44.21 (+0.19), BWC: 30.12 (-0.28), CPE: 6.09 (+0.03), FNV: 50.49 (+2.63), CTL: 39.95 (+0.11), ASH: 112.54 (+0.86), ENSG: 40.62 (-0.01), CLR: 54.55 (+0.33), ACAS: 15.49 (-0.02), G: 17.92 (-0.01), BREW: 13.70 (-0.13), AWK: 52.84 (-0.03), CVG: 21.34 (-0.12), AREX: 10.84 (+0.23), HTCH: 3.69 (-0.01), ETP: 64.80 (-0.57), ABTL: 10.66 (-0.03), FMI: 25.36 (+0.65), DPM: 51.59 (-0.68), BCOR: 14.54 (-0.16), CDE: 3.76 (+0.18), DRYS: 1.42 (-0.05), KW: 27.85 (-0.05), BALT: 3.23 (-0.04), ATO: 54.39 (+0.09), EXAR: 8.83 (+0.24), ACLS: 2.15 (unch), INWK: 7.60 (-0.04), ALSK: 1.37 (-0.08), CF: 264.52 (+10.12), EFC: 21.89 (-0.08), BIOS: 5.72 (+0.13), DYN: 34.23 (-0.26), DATA: 84.09 (+0.54), ANDE: 54.29 (-0.48), HOLX: 26.60 (+0.05), CBS: 51.90 (-0.23)

Zacks' Bull Of The Day: Kennedy Wilson
Zacks Investment Research - Seeking Alpha - Fri Oct 31, 3:37PM CDT
Kennedy-Wilson (NYSE: KW ) is the best treat for you to put into your plastic jack-o-lantern today. This Real Estate Operations Company is going to scare up a positive earnings spike as they build up to and announce their third quarter earnings on...
KW: 27.85 (-0.05)

Bull of the Day: Kennedy Wilson (KW) - Bull of the Day
Brian Hamilton - ZACKS - Fri Oct 31, 6:30AM CDT
Bull of the Day: Kennedy Wilson (KW) - Bull of the Day
KW: 27.85 (-0.05)

CBRE Posts Encouraging Q3 Earnings, Guides Up Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 10:20AM CDT
Real estate services firm, CBRE Group (CBG) reported third-quarter 2014 adjusted earnings of 40 cents per share, 4 cents ahead of the Zacks Consensus Estimate and up 33.3% year over year.
JLL: 140.89 (+0.87), CBG: 32.34 (+0.53), KW: 27.85 (-0.05)

JLL Beats Q3 Earnings on Revenue Growth, Hikes Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 9:20AM CDT
Helped by robust growth in fee revenue, JLL's third-quarter 2014 adjusted earnings of $2.31 per share comfortably exceeded the Zacks Consensus Estimate of $1.78.
JLL: 140.89 (+0.87), KW: 27.85 (-0.05), SRC: 11.70 (+0.02)

Kennedy Wilson Increases Its Presence in Denver Area with Purchase of 312-Unit Apartment Community
Business Wire - Thu Oct 30, 7:01AM CDT
Global real estate investment and services firm Kennedy Wilson (NYSE: KW) today announced that the Company and its equity partners purchased Villas at Homestead, a 312-unit apartment community located in Centennial, Colorado, for $56.75 million from DiNapoli Capital Partners. The Company and its equity partners invested an aggregate of $15.5 million of equity in the transaction (inclusive of closing costs) of which the Company's initial share is approximately 13%. The Company and its equity partners also assumed debt of $33.0 million through Fannie Mae and secured a coterminous supplemental seven-year floating rate loan of approximately $10.1 million.
KW: 27.85 (-0.05)

Will Microchip Technology Miss Earnings Estimates in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:30PM CDT
Microchip Technology (MCHP) is to report second-quarter fiscal 2015 results on Oct 30. Last quarter, the company failed to spring any surprise as earnings were in line with the Zacks Consensus Estimate.
MCHP: 43.43 (-0.06), KW: 27.85 (-0.05), JMI: 12.75 (-0.01), THRM: 40.82 (+0.05)

Kennedy Wilson to Announce Third Quarter 2014 Earnings
GlobeNewswire - Fri Oct 24, 7:00AM CDT
Global real estate investment and services firm Kennedy-Wilson Holdings, Inc. (NYSE:KW) will release its third quarter 2014 financial results on Wednesday, November 5, 2014 after the market closes. The company will hold a live conference call and webcast to discuss results at 7:00 a.m. PT/ 10:00 a.m. ET on Thursday, November 6, 2014.
KW: 27.85 (-0.05)

Kennedy-Wilson Holdings (KW): An Off-the-Radar Potential Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 7:45AM CDT
Kennedy-Wilson Holdings has been overlooked by investors but it has actually seen estimates rise over the past month.
KW: 27.85 (-0.05)

Why the Earnings Streak Will Continue for Kennedy-Wilson Holdings (KW) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 7:31AM CDT
Since the recent estimates have been moving higher for Kennedy-Wilson Holdings, it has high chance of beating the estimates in the coming quarter.
KW: 27.85 (-0.05)

Kennedy-Wilson Works On New Base With 26.84 Buy Point
at Investor's Business Daily - Wed Sep 17, 4:47PM CDT
Global real estate investment firm Kennedy-Wilson (KW) is working on a cup-with-handle base with a buy point at 26.84. But the stock has some flaws: It's fallen below its 10-week moving average this week in heavy volume and it trades fewer than...
KW: 27.85 (-0.05)

Kennedy Wilson Announces Dividend of $0.09 Per Common Share for Third Quarter 2014
Business Wire - Thu Sep 04, 9:35AM CDT
Global real estate investment and services firm Kennedy Wilson (NYSE: KW) today announced that the company will pay a dividend of $0.09 per share to common shareholders of record as of September 30, 2014 with a payment date of October 7, 2014. The quarterly payment equates to an annual dividend of $0.36 per common share.
KW: 27.85 (-0.05)

Kennedy Wilson Increases Its Presence in South Seattle Area with Purchase of 118-Unit Apartment Community
Business Wire - Tue Sep 02, 7:30AM CDT
Global real estate investment and services firm Kennedy Wilson (NYSE:KW) today announced that the company purchased a 100% interest in Tabula Rasa, an 118-unit apartment community located in Tumwater, Washington for $20.8 million. The asset was acquired from a financial institution which had been the lender on the property. Kennedy Wilson invested $8.0 million of equity in the transaction (inclusive of closing costs) and secured a seven-year $13.5 million loan through Freddie Mac.
KW: 27.85 (-0.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 105

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...